Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2026-03-13 @ 7:07 PM
Study NCT ID:
NCT03973918
Status:
TERMINATED
Last Update Posted:
2024-10-31
First Post:
2019-05-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-31
First Submit QC Date:
None
Study First Post Date:
2019-06-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-10-20
Results First Submit QC Date:
None
Results First Post Date:
2024-03-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-29
Last Update Post Date:
2024-10-31
Last Update Post Date Type:
ACTUAL